Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Etazolate
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Etazolate
Tree Number(s)
D03.066.515.400
D03.383.725.547.400
Unique ID
D004974
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D004974
Scope Note
A potent phosphodiesterase inhibitor proposed as an antipsychotic agent.
Entry Term(s)
Etazolate Hydrochloride
SQ-20009
Pharm Action
Phosphodiesterase Inhibitors
Antipsychotic Agents
Related Numbers
35838-58-5
51022-77-6
7YO3254Y6B
CAS Type 1 Name
1H-Pyrazolo(3,4-b)pyridine-5-carboxylic acid, 1-ethyl-4-((1-methylethylidene)hydrazino)-, ethyl ester
Previous Indexing
Hydrazines (1973-1975)
Nicotinic Acids (1975)
Pyrazoles (1973-1975)
Pyridines (1973-1974)
Public MeSH Note
91; was see under NICOTINIC ACIDS 1980-90; was SQ 20009 see under NICOTINIC ACIDS 1976-79
Online Note
use ETAZOLATE to search SQ 20009 1976-79
History Note
91(80); was see under NICOTINIC ACIDS 1980-90; was SQ 20009 see under NICOTINIC ACIDS 1976-79
Date Established
1991/01/01
Date of Entry
1975/07/25
Revision Date
2016/05/31
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
agonists (AG)
analogs & derivatives (AA)
analysis (AN)
antagonists & inhibitors (AI)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Heterocyclic Compounds [D03]
Acids, Heterocyclic [D03.066]
Nicotinic Acids [D03.066.515]
Arecoline [D03.066.515.292]
Clonixin [D03.066.515.375]
Etazolate [D03.066.515.400]
Niacin [D03.066.515.475]
Niacinamide [D03.066.515.530]
Niceritrol [D03.066.515.540]
Niflumic Acid [D03.066.515.550]
Pipemidic Acid [D03.066.515.635]
Piromidic Acid [D03.066.515.650]
Xanthinol Niacinate [D03.066.515.950]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Pyridines [D03.383.725]
Nicotinic Acids [D03.383.725.547]
Arecoline [D03.383.725.547.292]
Clonixin [D03.383.725.547.375]
Etazolate [D03.383.725.547.400]
Niacin [D03.383.725.547.475]
Niacinamide [D03.383.725.547.530]
Niceritrol [D03.383.725.547.540]
Niflumic Acid [D03.383.725.547.550]
Nimodipine [D03.383.725.547.570]
Pipemidic Acid [D03.383.725.547.635]
Piromidic Acid [D03.383.725.547.650]
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester [D03.383.725.547.900]
Xanthinol Niacinate [D03.383.725.547.950]
Expand All
Collapse All
Etazolate
Preferred
Concept UI
M0007803
Related Numbers
35838-58-5
51022-77-6
7YO3254Y6B
Scope Note
A potent phosphodiesterase inhibitor proposed as an antipsychotic agent.
Terms
Etazolate
Preferred Term
Term UI
T015175
Date
01/01/1999
LexicalTag
NON
ThesaurusID
SQ-20009
Narrower
Concept UI
M0007804
Terms
SQ-20009
Preferred Term
Term UI
T015176
Date
02/21/1979
LexicalTag
LAB
ThesaurusID
UNK (19XX)
Etazolate Hydrochloride
Narrower
Concept UI
M0352608
Terms
Etazolate Hydrochloride
Preferred Term
Term UI
T015177
Date
07/25/1994
LexicalTag
NON
ThesaurusID
page delivered in 0.166s